Drug
Axs 07
Axs 07: highest development phase Phase 3, developed by Axsome Therapeutics. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Axsome Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| AXS-07 (meloxicam-rizatriptan) NCT05550207 | Phase 3 | Migraine |
| AXS-07 (MoSEIC meloxicam and rizatriptan) NCT04163185 | Phase 3 | Migraine |
| AXS-07 (MoSEIC meloxicam and rizatriptan) NCT03896009 | Phase 3 | Migraine |
Latest
No recent events.
Follow Axs 07 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.